3-rx.comCustomer Support3-rx.com
Find a product
    HomeAbout UsFAQContactHelp
 
   
 
News Center
Health Centers
Medical Encyclopedia
Drugs & Medications
Diseases & Conditions
Medical Symptoms
Med. Tests & Exams
Surgery & Procedures
Injuries & Wounds
Diet & Nutrition
Special Topics
Online Pharmacy



Tacrolimus ( ta-KROE-li-mus) ointment is used for moderate to severe atopic dermatitis. This is a skin condition where there is itching, redness and inflammation, much like an allergic reaction


Join our Mailing List

Men`s Health sites at Top100biz.com




Syndicate

You are here : 3-RX.com > Home > Diabetes -

Antidepressants extend time to relapse in diabetics

DiabetesMay 02, 06

Maintenance treatment with the antidepressant sertraline (Zoloft) after a first episode of depression has resolved extends the time to relapse in patients with diabetes, study results suggest. And sustained remission of depression is associated with improved control of blood sugar.

Depression is highly prevalent among patients with diabetes, Dr. Patrick J. Lustman, from Washington University School of Medicine in St. Louis, and colleagues note, and recurrence after initial successful treatment is common. Depression, in turn, is linked to increased morbidity and mortality among diabetics, they point out in the Archives of General Psychiatry for May.

Previous studies have been limited to no more than 16 weeks of treatment, the authors report. The goal of the current study was to see if continued antidepressant treatment beyond the first remission would be effective in prolonging depression-free periods and improving glycemic (blood sugar) control.

In the first phase of the study, 351 diabetic patients with moderately severe and recurrent major depression were treated with Zoloft, up to 200 mg/day for 16 weeks. Recovery occurred in 156 (44 percent).

The second phase of the trial included 152 diabetics from the first group who were successfully treated for depression. Seventy-nine were randomly assigned to continued Zoloft and 73 to placebo.

Zoloft was significantly more successful than placebo in prolonging the depression-free interval, report the investigators. Time to recurrence in one third of patients was 57 days in the placebo group and 226 days in the Zoloft group.

During the second phase of the trial, changes in HbA1c level—a marker of blood sugar control—did not differ between groups. However, HbA1c levels were significantly lower than baseline during depression-free periods, regardless of treatment.

According to Lustman’s group: “Vigilant monitoring of depression symptoms to prompt treatment augmentation or modification is required and may improve the picture.” They also suggest that psychotherapy may help provide more durable relief of depression.

SOURCE: Archives of General Psychiatry May 2006.



Print Version
Tell-a-Friend

RELATED ARTICLES:
  Diabetic women more likely to die after heart attack
  Heart problems often worse in diabetic women
  Sealing off portion of intestinal lining treats obesity, resolves diabetes in animal model
  Study Sheds Light on Participants in National SEARCH for Diabetes in Youth Study
  Pregnancy diabetes doubles the risk of language delay in children
  Clinical Guideline on Prevention of Cardiovascular Disease and Diabetes in Patients at Highest Risk
  Obesity, other health problems delay MS diagnosis
  If the diabetes has a direct carcinogenetic effect?
  Cost of diabetes treatment escalating in US
  Moderate Use Averts Failure of Type 2 Diabetes Drugs in Animal Model
  Moderate Use May Avert Failure of Type 2 Diabetes Drugs
  Fasting may cut risks of heart disease, diabetes

 


Advertisement
















Home | About Us | FAQ | Contact | Advertising Policy | Privacy Policy | Bookmark Site